Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

Delcath Systems Inc

+ Add to Watchlist

DCTH:US

1.0400 USD 0.00000.00%

As of 20:10:00 ET on 04/24/2015.

Snapshot for Delcath Systems Inc (DCTH)

Open: 1.0214 Day's Range: 1.0214 - 1.0500 Volume: 26,293
Previous Close: 1.0400 52wk Range: 0.9101 - 3.8400 1-Yr Rtn: -71.51%

Stock Chart for DCTH

No chart data available.
  • DCTH:US 1.0400
  • 1D
  • 1M
  • 1Y
1.0400
Interactive DCTH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DCTH

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.6239
Est. EPS (USD) (12/2015) -
Est. PEG Ratio -
Market Cap (M USD) 12.66
Shares Outstanding (M) 12.17
30 Day Average Volume 81,674
Price/Book (mrq) 0.5565
Price/Sale (ttm) 9.1921
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DCTH

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DCTH

Delcath Systems Inc. has developed a system to isolate the liver from the circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. This system filters the patients blood removing most of the harmful chemotherapy agents lessening the side-effects of the treatment.

Roger G StollChairmanJennifer SimpsonInterim President & CEO
Barbra C KeckVP/CFO/ControllerGregory J ChampionSecretary
More Company Profile & Key Executives for DCTH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil